Hundreds of posters depicting members of the University of Rochester's Jewish community as "wanted" were found in buildings ...

HUNTINGTON More than 200 students and post-doctoral residents and fellows participated in the 36th annual Marshall University Health Sciences Research Day on Nov. 1 at Marshall University Medical ...

Completed a successful end of Phase 2 meeting with the FDA for bitopertin in erythropoietic protoporphyria (EPP), reaching alignment on all ...

MIAMI, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology ...

A meme purports to outline what it calls "The Trump-Vance Project 2025 Plan," although both U.S. President-elect Trump and ...

Cuba is currently preparing to welcome delegates from the island and various nations who will attend the 1st International ...

“But after returning home, I met an emergency medicine physician who had worked in a different ... professors and others had ...

The world’s carbon intensity dropped by 1.02 per cent last year, the slowest decrease in more than a decade, according to the ...

FDA confirmed in a recent FDA Type B meeting under RMAT designation that the PROACT 1 Phase 3 study could be sufficient to support a full U.S. regulatory approval of rilparencel; ...

Prothena expects to report multiple clinical readouts starting in mid-2025 and continuing throughout the year from the ongoing Phase 1 ASCENT clinical trials Prothena has currently enrolled ...

Key players in the artificial intelligence (AI) in drug discovery are NVIDIA Corporation (US), Exscientia (UK), Google (US), ...

A poster titled "Enhanced MSI Status Determination from FFPE ... Learn more at promega.com QuantumCyte enables DNA and RNA purification to address the high demand for precision medicine and AI-powered ...